JUNS
Jupiter Neurosciences, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Jupiter Neurosciences (JUNS) Stock: Buy, Sell, or Hold?
$1.86
-0.28 (-13.08%)
▼
5d:
-12.68%
30d:
-41.69%
90d:
-64.5%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (85%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$2.24 – $2.98
Position: OVERSOLD
Forward P/E & Valuation
31.0x
STRETCHED
vs 22.7x historical avg
Wall Street Target
$30.00
+1512.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.79 / $2.50
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: JUNS is down 12.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When JUNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: JUNS is currently trading at $1.86, which is considered oversold relative to its 30-day fair value range of $2.24 to $2.98. From a valuation perspective, the stock is trading at a premium (Forward PE: 31.0) compared to its historical average (22.7). At these levels, the market is pricing in 10.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, JUNS is in a uptrend. Immediate support is located at $1.78, while resistance sits at $2.50. Short-term momentum is weak, with the stock down 13.1% recently.
Market Sentiment: JUNS scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+1512.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JUNS is in a uptrend. Immediate support is located at $1.78, while resistance sits at $2.50. Short-term momentum is weak, with the stock down 13.1% recently.
Market Sentiment: JUNS scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+1512.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.24 -
$2.98
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.8%
Trading Range & Key Levels
30-Day Trading Range
$2.24 -
$2.98
Current vs Trading Range
OVERSOLD
Support Level
$1.79
Resistance Level
$2.50
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-13.1%)
- BULLISH: Trading 1512.9% below Wall St target ($30.00)
- NEUTRAL: Trading at premium valuation - market expects 10.9% growth which is achievable
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
31.00
Wall Street Target
$30.00
(+1512.9%)
Valuation Premium vs History
+10.9% premium
PE vs Historical
31.0 vs 22.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.9%
(market-implied from PE analysis)
1-Year Target
$2.06
(+11%)
2-Year Target
$2.29
(+23%)
3-Year Target
$2.54
(+36%)
3-Yr Target (if PE normalizes)
(PE: 31→23)
PE COMPRESSION
$1.86
(0%)
Earnings growth offset by PE compression
Share JUNS Analysis
Share this live JUNS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (JUNS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses excitement for $JUNS stock ahead of tomorrow's trading session.
Key Retail Themes:
bullish sentiment
anticipation
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:49 AM ET
Data refreshes hourly during market hours. Next update: 5:49 AM
Data refreshes hourly during market hours. Next update: 5:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JUNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 30 SELL |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
PVLA
Palvella Therapeutics, I… |
STRONG BUY
16 analysts |
$233 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive JUNS Research Pages
